Introducing Valeda: A Breakthrough in Dry Macular Degeneration Treatment
We are excited to bring incredible news to patients in Venice, North Port, Englewood, Nokomis, and Port Charlotte—a revolutionary treatment for dry age-related macular degeneration (AMD) is now available at Venice Retina. Valeda, an FDA-approved photobiomodulation (PBM) therapy, offers new hope for managing dry AMD. Already widely used in Europe, this innovative treatment is now improving lives here in the United States.
Clinical studies have shown that Valeda can enhance vision, reduce drusen deposits, and help prevent the progression of geographic atrophy with consistent use. For those struggling with vision loss caused by dry macular degeneration, this groundbreaking therapy offers an exciting opportunity for better retinal health.
If you or a loved one is living with dry AMD, don’t wait—this could be the solution you’ve been searching for.
What Is Dry Macular Degeneration?
Dry macular degeneration is one of the leading causes of vision loss in individuals over 50. As this condition progresses, it causes retinal atrophy and the formation of blind spots in central vision, which can grow larger over time. The effects on everyday tasks, like reading, driving, or recognizing loved ones’ faces, can be life-changing.
While lifestyle changes and AREDS2 supplements may help slow the disease’s progression, no treatment has been available to actively restore and protect vision — until now.
How Does Valeda Work?
Valeda is an innovative treatment that uses precise wavelengths of red and infrared light to address the cellular processes involved in dry macular degeneration (AMD). Through photobiomodulation (PBM), Valeda stimulates mitochondrial activity, supports healthy cell metabolism, and helps reduce inflammation and cell death. This advanced therapy works to slow the progression of dry AMD, improve vision, and even decrease drusen—the small yellow deposits that build up in the retina.
Clinical Benefits of Valeda
Valeda has delivered remarkable results in clinical trials. In the LIGHTSITE III trial, patients who underwent photobiomodulation (PBM) therapy experienced:
- Improved visual acuity, with an average gain of more than one line on the eye chart after one and two years of treatment.
- Reduced drusen volume, decreasing the macular deposits associated with vision loss.
- Slowed progression of geographic atrophy, with significantly fewer cases of this condition in treated patients compared to those receiving a sham treatment.
These clinical findings are an exciting step forward, offering patients with dry macular degeneration (AMD) a proven option to maintain vision and slow disease progression.
Treatment Details
Valeda uses a cutting-edge light delivery system to emit red and infrared light. The treatment is non-invasive, safe, and performed through multiple sessions over a few weeks.
- Treatment Schedule: Most patients complete a series of 9 treatment sessions over 3-5 weeks. After the initial series, follow-up treatments are typically scheduled every 4 months.
- No Pain: Valeda is well-tolerated, with most patients reporting no pain or discomfort during the procedure.
- FDA Approval: Valeda is the first FDA-approved device for dry macular degeneration (AMD) and the first treatment specifically for intermediate dry AMD. It represents a groundbreaking advancement for patients with this condition.
Is Valeda Right for You?
Valeda is an excellent option for patients with dry macular degeneration (AMD) who have drusen or non-central geographic atrophy. However, this treatment is not recommended for individuals with wet AMD or for those who have advanced vision loss caused by central macular atrophy.
Valeda Light Therapy FAQ
What is photobiomodulation (PBM)?
PBM is a non-invasive light therapy that activates cellular processes in the retina. It enhances energy production within cells, reduces inflammation, and promotes cell survival—key factors in managing dry macular degeneration (AMD).
How often will I need treatment with Valeda light therapy?
Valeda treatments are typically delivered in a series of nine sessions over 3-5 weeks. After completing the initial series, your retina specialist will recommend follow-up cycles every four months to maintain results.
How long is each Valeda light therapy session?
Each Valeda photobiomodulation session lasts approximately 20 minutes in a seated position. No dilation or additional testing is required during the visit.
Do I have to be dilated for Valeda light therapy?
No, Valeda light therapy does not require dilation, drops, or medication during the session.
Does Valeda light therapy cure dry AMD?
Valeda does not cure dry AMD. However, it slows disease progression and improves vision, helping patients maintain functional vision longer.
What are the risks of Valeda light therapy?
Valeda has shown a strong safety profile in clinical trials with no significant risks or side effects. Patients with photosensitivity or who have recently used photosensitizing medications should consult their doctor before starting treatment.
How soon can I expect results?
The LIGHTSITE III study showed significant improvement in vision within five months, with ongoing benefits over the two-year trial period.
Does insurance cover Valeda PBM?
Insurance coverage for Valeda varies. Our office can assist you with verifying your benefits and exploring payment options.
When will treatments begin?
Venice Retina is proud to offer Valeda PBM to our patients starting in early 2025. Contact us today to reserve your consultation.
Patient Testimonials
This is the best and most talented eye surgeon you could ever want! My husband had eye surgery with Dr Shane and I know another gal that had the same surgery with another doctor. My husband had to be face down for a week the other patient was not told to do that he had a full recovery the other patient with the other doctor is now blind in that eye. In addition she’s married to another fabulous eye doctor who has been caring for my mother in Sarasota who is 97 with macular degeneration and she’s still able to drive her electric wheelchair! These two physicians in Sarasota County are top shelf Dr Anita Shane in Venice and Dr Shane in Sarasota they are in my opinion a blessing to our community and we are so lucky to have them!
Get Started with Valeda Light Therapy for Dry Macular Degeneration Today!
If you or a loved one is living with dry macular degeneration, contact us today to schedule a consultation. Our expert team at Venice Retina will evaluate your condition and determine if Valeda light therapy is the best option for your treatment plan. Don’t wait—take control of your vision and let us help protect your sight!
At Venice Retina, we proudly offer the latest and most advanced treatments for macular degeneration to patients in Venice, North Port, Englewood, Nokomis, and Port Charlotte. For more information or to schedule your appointment, please call our office at (941) 202-1900.
